We are live on ! Find out more
LMNL

Liminal BioSciences Inc. Common Shares
LMNL

Delisted

LMNL was delisted on the 25th of September, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Liminal BioSciences Inc. Common Shares in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.55% less ownership

Funds ownership: 0.55% → 0% (-0.55%)

88% less funds holding

Funds holding: 8 → 1 (-7)

100% less capital invested

Capital invested by funds: $108K → $0 (-$108K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

Holders
1
Holders Change
-7
Holders Change %
-87.5%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$61.1K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$21.2K
3
Morgan Stanley
Morgan Stanley
New York
-$10.7K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$7K
5
UBS Group
UBS Group
Switzerland
-$4.49K

LMNL Hedge Fund Activity: Q3 2023 in Review

1 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q3 2023, worth a combined $0 — down 100% from $108K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LMNL and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was National Bank of Canada, exiting entirely with an estimated $61.1K sold.

  • 1 institutional investor held Liminal BioSciences Inc. Common Shares (LMNL) as of Q3 2023, down from 8 in Q2 2023.
  • Funds reported $0 of Liminal BioSciences Inc. Common Shares stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Liminal BioSciences Inc. Common Shares positions in Q3 2023 and 7 closed out, a net change of -7 holders.
  • The largest Liminal BioSciences Inc. Common Shares seller in Q3 2023 was National Bank of Canada, an estimated $61.1K sold.

Based on aggregated 13F filings for Q3 2023.